KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Other Non-Current Assets (2017 - 2025)

Elanco Animal Health's Other Non-Current Assets history spans 9 years, with the latest figure at $304.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets fell 2.25% year-over-year to $304.0 million; the TTM value through Dec 2025 reached $304.0 million, down 2.25%, while the annual FY2025 figure was $304.0 million, 2.25% down from the prior year.
  • Other Non-Current Assets for Q4 2025 was $304.0 million at Elanco Animal Health, down from $306.0 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $651.0 million in Q1 2024 and bottomed at $302.0 million in Q3 2024.
  • The 5-year median for Other Non-Current Assets is $363.0 million (2021), against an average of $374.5 million.
  • The largest annual shift saw Other Non-Current Assets surged 76.42% in 2024 before it tumbled 52.07% in 2025.
  • A 5-year view of Other Non-Current Assets shows it stood at $387.0 million in 2021, then decreased by 2.33% to $378.0 million in 2022, then fell by 9.79% to $341.0 million in 2023, then dropped by 8.8% to $311.0 million in 2024, then fell by 2.25% to $304.0 million in 2025.
  • Per Business Quant, the three most recent readings for ELAN's Other Non-Current Assets are $304.0 million (Q4 2025), $306.0 million (Q3 2025), and $308.0 million (Q2 2025).